These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18330213)

  • 1. Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Antke C; Kley K; Forutan F; Wirrwar A; Müller HW
    Rev Neurosci; 2007; 18(6):473-504. PubMed ID: 18330213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans.
    Nikolaus S; Antke C; Kley K; Poeppel TD; Hautzel H; Schmidt D; Müller HW
    Rev Neurosci; 2007; 18(6):439-72. PubMed ID: 18330212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
    Nikolaus S; Larisch R; Vosberg H; Beu M; Wirrwar A; Antke C; Kley K; Silva MA; Huston JP; Müller HW
    Rev Neurosci; 2011; 22(6):625-45. PubMed ID: 22103308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAT versus D2 receptor binding in the rat striatum: l-DOPA-induced motor activity is better predicted by reuptake than release of dopamine.
    Nikolaus S; Beu M; Angelica De Souza Silva M; Huston JP; Hautzel H; Antke C; Müller HW
    Synapse; 2016 Sep; 70(9):369-77. PubMed ID: 27164322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment with L-DOPA may reduce striatal dopamine transporter binding in in vivo imaging studies.
    Nikolaus S; Antke C; Hautzel H; Mueller HW
    Nuklearmedizin; 2016; 55(1):21-8. PubMed ID: 26642370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function.
    Parish CL; Nunan J; Finkelstein DI; McNamara FN; Wong JY; Waddington JL; Brown RM; Lawrence AJ; Horne MK; Drago J
    Mol Pharmacol; 2005 Nov; 68(5):1376-86. PubMed ID: 16077034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review.
    Laruelle M
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):423-51. PubMed ID: 10724107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.
    Nikolaus S; Larisch R; Wirrwar A; Jamdjeu-Nouné M; Antke C; Beu M; Schramm N; Müller HW
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1305-10. PubMed ID: 16003562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.
    Sossi V; Dinelle K; Topping GJ; Holden JE; Doudet D; Schulzer M; Ruth TJ; Stoessl AJ; de la Fuente-Fernandez R
    J Neurochem; 2009 Apr; 109(1):85-92. PubMed ID: 19183257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
    Fasano C; Poirier A; DesGroseillers L; Trudeau LE
    Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour.
    Lee J; Parish CL; Tomas D; Horne MK
    Neuroscience; 2011 Feb; 174():143-50. PubMed ID: 21129449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
    Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
    Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.